다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Best practice & research. Clinical gastroenterology, v.19 no.3, 2005년, pp.359 - 371
Ciclitira, Paul J. (Corresponding author. Tel.: +44 20 7188 5609) , Ellis, H. Julia (Fax: +44 20 7261 0667.)
AI-Helper
The cornerstone of treatment of coeliac disease is a gluten-free diet devoid of proteins from wheat, rye, barley and related cereals. Oats are tolerated by most patients with coeliac disease but are not totally innocent. There are considerable differences between individual patients with respect to ...
Digestion Ciacci 66 178 2002 10.1159/000066757 Long-term follow-up of coeliac adults on gluten-free diet: prevalence and correlates of intestinal damage
Gut Holmes 30 333 1989 10.1136/gut.30.3.333 Malignancy in coeliac disease-effect of a gluten free diet
Gastroenterology Ventura 117 297 1999 10.1053/gast.1999.0029900297 Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease
Gut Scott 46 supplement 1 i1 2000 10.1136/gut.46.suppl_1.I1 Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology
J Exp Med Lundin 178 187 1993 10.1084/jem.178.1.187 Gliadin specific, HLA-DQ (α1*0501, β1*0201) restricted T-cells isolated from the small intestinal mucosa of patients with coeliac disease
Gastroenterology Arentz-Hansen 123 803 2002 10.1053/gast.2002.35381 Celiac lesion T-cells recognize epitopes that cluster in regions rich in proline residues
J Exp Med Vader 195 643 2002 10.1084/jem.20012028 Specificity of tissue transglutaminase explains cereal toxicity in celiac disease
Science Shan 297 2275 2002 10.1126/science.1074129 Structural basis for gluten intolerance in celiac sprue
Nat Med Anderson 6 337 2000 10.1038/73200 In vivo antigen challenge in coeliac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope
J Exp Med Arentz-Hansen 191 603 2000 10.1084/jem.191.4.603 The intestinal T-cell response to α-gliadin in adult coeliac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase
Nat Med Molberg 4 713 1998 10.1038/nm0698-713 Tissue transglutaminase selectively modifies gliadin peptides that are recognised by gut-derived T-cells in coeliac disease
Lancet Maiuri 362 30 2003 10.1016/S0140-6736(03)13803-2 Association between innate response to gliadin and activation of pathogenic T-cells in coeliac disease
Immunity Hue 21 367 2004 10.1016/j.immuni.2004.06.018 A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease
Immunity Meresse 21 357 2004 10.1016/j.immuni.2004.06.020 Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease
Bailliere's Clin Gastroenterol Wieser 9 191 1995 10.1016/0950-3528(95)90027-6 The precipitating factor in coeliac disease
Acta Paediatrica Dicke 42 34 1953 10.1111/j.1651-2227.1953.tb05563.x Coeliac disease, The presence in wheat of a factor having a deliterious effect in cases of coeliac disease
Lancet Frazer 2 252 1959 10.1016/S0140-6736(59)92051-3 Gluten-induced enteropathy. The effect of partially digested gluten
Hekkens 11 1970 Coeliac Disease Some aspect of gliadin fractionation and testing by histochemical methods
Clin Sci (Lond) Ciclitira 66 357 1984 10.1042/cs0660357 Clinical testing of gliadin fractions in coeliac patients
Eur J Immunol Van De Wal 29 3133 1999 10.1002/(SICI)1521-4141(199910)29:10<3133::AID-IMMU3133>3.0.CO;2-G Glutenin is involved in the gluten-driven mucosal T cell response
Gastroenterology Vader 122 1729 2002 10.1053/gast.2002.33606 The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides
Gastroenterology Molberg 125 337 2003 10.1016/S0016-5085(03)00890-4 Intestinal T-cell responses to high-molecular-weight glutenins in coeliac disease
Gastroenterology Dewar 126 supplement 2 A-290 2004 The immunogenicity and in vivo toxicity of HMW glutenins in celiac disease
J Immunol Methods Ellis 120 17 1989 10.1016/0022-1759(89)90283-4 The production and characterisation of monoclonal antibodies to wheat gliadin peptides
Gut Ellis 43 190 1998 10.1136/gut.43.2.190 Measurement of gluten using a monoclonal antibody to a coeliac-toxic peptide of A-gliadin
J Assoc Off Anal Chem Skerritt 74 257 1991 Enzyme immunoassay for determination of gluten in foods: collaborative study
Eur J Gastroenterol Hepatol Valdes 15 465 2003 10.1097/01.meg.0000059119.41030.df Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol
Gut Spaenij-Dekking 53 1267 2004 10.1136/gut.2003.037952 A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin
J Clin Invest Browing 48 1423 1969 10.1172/JCI106108 Organ culture of mucosal biopsies of human small intestine
Lancet Townley 1 1363 1973 10.1016/S0140-6736(73)91679-6 Toxicity of wheat gliadin fractions in coeliac disease
Gastroenterology De Ritis 94 41 1988 10.1016/0016-5085(88)90607-5 In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in coeliac disease
Hum Immunol Gjertsen 39 243 1994 10.1016/0198-8859(94)90267-4 T-cells recognise a peptide derived from α-gliadin presented by the coeliac disease associated HLA-DQ (α1*0501, β1*0201) heterodimer
Scand J Immunol Halstensen 38 561 1993 10.1111/j.1365-3083.1993.tb03245.x Gluten stimulation of coeliac mucosa induces activation (CD25) of lamina propria CD4+ T-cells and macrophages but no crypt-cell hyperplasia
Gastroenterology Maiuri 110 1368 1996 10.1053/gast.1996.v110.pm8613040 Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients
Gastroenterology Maiuri 115 564 1998 10.1016/S0016-5085(98)70135-0 Blockage of T-cell costimulation inhibits T-cell activation in celiac disease
Gastroenterology Mauri 119 996 2000 10.1053/gast.2000.18149 Interleukin 15 mediates epithelial changes in celiac disease
Gut Maiuri 48 418 2001 10.1136/gut.48.3.418 FAS engagement drives apoptosis of enterocytes of coeliac patients
Gut Mazzarella 52 57 2003 10.1136/gut.52.1.57 An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune responses in in vivo cultured mucosa from HLA-DQ8 positive but not from HLA-DQ8 negative coelaic patients
Eur J Gastroenterol Hepatol Martucci 15 1293 2003 10.1097/00042737-200312000-00007 Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system
Gut Fraser 52 1698 2003 10.1136/gut.52.12.1698 Coeliac disease: in vivo toxicity of the putative immunodominant epitope
Lancet Sturgess 343 758 1994 10.1016/S0140-6736(94)91837-6 Wheat peptide challenge in coeliac disease
Bailliere's Clin Gastroenterol Marsh 9 273 1995 10.1016/0950-3528(95)90032-2 Morphology of the mucosal lesion in gluten sensitivity
Scand J Gastroenterol Mantzaris 26 392 1991 10.3109/00365529108996500 In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease
Lancet Loft 335 1293 1990 10.1016/0140-6736(90)91183-B Rectal gluten challenge and diagnosis of coeliac disease
Clin Sci Ensari 95 419 1998 10.1042/CS19980129 Studies in vivo of omega-gliadins in gluten sensitivity (coeliac sprue disease)
Clin Exp Immunol Lahteenoja 120 38 2000 10.1046/j.1365-2249.2000.01177.x Local challenge of the oral mucosa with gliadin in patients with coeliac disease
Clin Sci Ensari 101 199 2001 10.1042/CS20000331 Diagnosing coeliac disease by rectal gluten challenge: a prospective study based on immunopathology, computerized image analysis and logistic regression analysis
Aliment Pharmacol Ther Peraaho 17 587 2003 10.1046/j.1365-2036.2003.01425.x Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study
Aliment Pharmacol Ther Collin 19 1277 2004 10.1111/j.1365-2036.2004.01961.x The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in treatment of coeliac disease?
Gastroenterology Fasano 120 636 2001 10.1053/gast.2001.22123 Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum
Eur J Gastroenterol Hepatol Stern 13 741 2001 10.1097/00042737-200106000-00023 Analysis and clinical effects of gluten in coeliac disease
Eur J Gastroenterol Hepatol van Overbeek 9 1097 1997 10.1097/00042737-199711000-00013 The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population
Z Lebensm Unters Forsch Forsell 201 35 1995 Spelt wheat and celiac disease
10.1053/j.gastro.2004.11.003 Molberg O, Uhlen AK, Jensen T, et al. Mapping of gluten T-cell epitopes in the bread wheat ancestors; Implications for coeliac disease. Gastroenterology 2005.
Am J Physiol Gastrointest Liver Physiol Hausch 283 G996 2002 10.1152/ajpgi.00136.2002 Intestinal digestive resistance of immunodominant gliadin peptides
Appl Environ Microbiol Di Cagno 70 1088 2004 10.1128/AEM.70.2.1088-1096.2004 Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in coeliac sprue patients
Clin Chim Acta Ellis 189 123 1990 10.1016/0009-8981(90)90082-4 Detection and estimation of the barley prolamin content of beer and malt to assess their suitability for patients with coeliac disease
Int Arch Allergy Immunol Ellis 104 308 1994 10.1159/000236683 Demonstration of the presence of coeliac-activating gliadin-like epitopes in malted barley
Nutr Rev Biagi 62 360 2004 10.1111/j.1753-4887.2004.tb00062.x A milligram gluten a day keeps the mucosal recovery away: a case report
N Engl J Med Janatuinen 333 1033 1995 10.1056/NEJM199510193331602 A comparison of diets with and without oats in adults with coeliac disease
Gut Janatuinen 50 332 2002 10.1136/gut.50.3.332 No harm from five year ingestion of oats in coeliac disease
Br Med J Srinivasan 313 1300 1996 10.1136/bmj.313.7068.1300 Absence of oats toxicity in adult coeliac disease
Eur J Clin Nutr Storsrud 57 163 2003 10.1038/sj.ejcn.1601525 Adult coeliac patients do tolerate large amounts of oats
N Eng J Med Hardman 337 1884 1997 10.1056/NEJM199712253372604 Absence of toxicity of oats in patients with demratitis herpetiformis
Gut Reunala 43 490 1998 10.1136/gut.43.4.490 Tolerance to oats in dermatitis herpetiformis
J Pediatr Hoffenberg 137 361 2000 10.1067/mpd.2000.109003 A trial of oats in children with newly diagnosed coeliac disease
Gut Hogberg 53 649 2004 10.1136/gut.2003.026948 Oats to children with newly diagnosed coeliac disease: a randomized double blind study
Gut Lundin 52 1649 2003 10.1136/gut.52.11.1649 Oats induced villous atrophy in coeliac disease
PloS Med Arentz-Hansen 1 84 2004 10.1371/journal.pmed.0010001 The molecular basis for oat intolerance in patients with coeliac disease
Scand J Gastroenterol Peraaho 39 27 2004 10.1080/00365520310007783 Effect of an oats-containing gluten-free diet on symptoms and quality of life in coeliac disease. A randomized study
N Eng J Med Thompson 351 2021 2004 10.1056/NEJM200411043511924 Gluten contamination of commercial oat products in the United States
Gut Ellis 52 212 2003 10.1136/gut.52.2.212 Investigation of the putative immunodominant T cell epitopes in coeliac disease
Gastroenterology Vader 125 1105 2003 10.1016/S0016-5085(03)01204-6 Characterization of cereal toxicity for celiac disease patients based on protein homology in grains
Gahrtz M, Wieser H, Schroder M, et al. Expression of wheat storage proteins in maize endosperm, poster presentation at the 7th International Congress of Plant Molecular Biology, Barcelona, abstr., 2003, pp. S10-85.
J Pharmacol Exp Ther Marti 312 19 2005 10.1124/jpet.104.073312 Prolyl endopeptidase mediated destruction of T-cell epitopes in whole gluten-chemical and immunological characterization
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.